James F. Cummings - 28 Mar 2023 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role
Chief Medical Officer
Signature
/s/ Edward Berg, Attorney-in-Fact
Issuer symbol
VXRT
Transactions as of
28 Mar 2023
Net transactions value
-$6,312
Form type
4
Filing time
20 Mar 2025, 21:43:44 UTC
Previous filing
21 Mar 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VXRT Common Stock Tax liability $2,451 -3,267 -0.93% $0.7502 349,821 28 Mar 2023 Direct F1, F2
transaction VXRT Common Stock Tax liability $3,861 -6,772 -1.9% $0.5702 343,049 18 Mar 2025 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction is being reported late due to administrative oversight.
F2 Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 28, 2023.
F3 Represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of RSUs vested as of March 18, 2025.
F4 Includes 75,618 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney